Exploring the Next Era of Cell & Gene Therapy with Nobel Laureate in London
PISCATAWAY, N.J., Oct. 20, 2025 /PRNewswire/ -- London will become the global spotlight for cell and gene therapy (CGT) this November as Nobel Laureate, scientific leaders, biotech innovators, and top investors convene to chart the future of one of...
Clover Appoints Nicholas Jackson, Ph.D., as President of Global R&D and Alliances
SHANGHAI, Oct. 20, 2025 /PRNewswire/ -- Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global commercial-stage biotechnology company committed to unleashing the power of innovative vaccines to save lives and improve health around the...
The Department of Health - Abu Dhabi and Sanofi Forge Strategic Alliance to Accelerate the Development of New Global Vaccines in Abu Dhabi
On the sidelines of a high-level US visit focused on healthcare innovation ABU DHABI, UAE, June 19, 2025 /PRNewswire/ -- The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in Abu Dhabi, has signed a Memorandum of...
Tencent Cloud Commits to Support European Companies' Global Competitiveness and Realise AI Ambitions
PARIS, June 16, 2025 /PRNewswire/ -- At Viva Technology 2025, Europe's largest technology event, Tencent Cloud highlighted the accelerating shift among enterprises toward connected platforms and multi-cloud strategies, key enablers for unlocking the...
SK bioscience Wins Patent Lawsuit Against Pfizer Over Pneumococcal Vaccine
No patent infringement found in exports of individual conjugate bulk substances and research-use finished products of PCV13 to Russia Company plans to export PCV13 vaccine components "We aim for the global PCV market with our 21-valent and...
Dupixent approved in Singapore as the first-ever biologic medicine for patients with COPD
Following recent approvals in the EU, US and China, the Singapore approval is based on two replicate phase 3 studies that showed Dupixent achieved significant reduction in exacerbations, and also showed improvements in lung function and...
Sanofi and Sobi extend their partnership with the World Federation of Hemophilia Humanitarian Aid Program
Up to five-year contract extension to support the WFH Humanitarian Aid Program with medicine donations and financial assistance MONTREAL, April 25, 2025 /PRNewswire/ -- The World Federation of Hemophilia (WFH) and WFH USA, together with Sanofi,...
Earendil Labs Announces Worldwide Exclusive License Agreement with Sanofi for Next-Generation Bispecific Antibodies for Autoimmune and Inflammatory Bowel Diseases
MIDDLETOWN, Del., April 17, 2025 /PRNewswire/ -- Earendil Labs, a global leader in AI-driven research and development of next-generation biologics therapeutics, and Sanofi today announced that they have entered into a license agreement for two...
VIVATECH 2025 EXPLORES THE NEW FRONTIERS OF INNOVATION
PARIS, April 3, 2025 /PRNewswire/ -- The 9th edition of VivaTech, Europe's largest startup and tech event, will take place in Paris Porte de Versailles from 11 to 14 June 2025. VivaTech 2025 Press Conference SPANNING A DECADE OF TECHNOLOGICAL...
Global Times: China remains an 'ideal, secure and promising' destination for foreign investors: Xi
BEIJING, April 1, 2025 /PRNewswire/ -- As China wraps up a week in which it hosted two top-level international forums - the China Development Forum (CDF) 2025 and the Boao Forum for Asia (BFA) Annual Meeting 2025 - to drive home its commitment to...